Vergoeding 2020-2024 voor ATC-subgroep C08CA : Dihydropyridinederivaten
- Raming voor de totale Zvw-populatie
| 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| C08CA01 Amlodipine (Norvasc ®) | 5.515.300 | 5.680.300 | 6.152.100 | 6.902.100 | 10.890.900 |
| C08CA02 Felodipine (Plendil ®) | 557.010 | 526.320 | 509.110 | 451.580 | 446.940 |
| C08CA05 Nifedipine (Nifedipin-ratiopharm ®) | 6.825.400 | 6.860.600 | 7.095.300 | 9.593.700 | 10.573.100 |
| C08CA06 Nimodipine (Nimotop ®) | 15.148 | 15.344 | 14.417 | 11.018 | 4.920 |
| C08CA09 Lacidipine | 75.811 | 81.044 | 73.219 | 65.573 | 44.021 |
| C08CA12 Barnidipine (Cyress ®) | 18.700.800 | 19.483.700 | 20.534.500 | 21.710.300 | 21.689.300 |
| C08CA13 Lercanidipine (Lerdip ®) | 1.229.300 | 1.300.700 | 1.399.000 | 1.428.000 | 1.637.500 |
| Totaal | 32.918.769 | 33.948.008 | 35.777.646 | 40.162.271 | 45.286.681 |